<DOC>
	<DOCNO>NCT00088517</DOCNO>
	<brief_summary>This study investigate use [ 11C ] NNC-112 positron emission tomography ( PET ) scan . PET technique use radioactive isotope call tracer provide image brain . Injected body , isotopes lose `` radioactive strength '' time , send ray pick `` see '' special detector connect computer . The computer make picture brain . This study examine distribution body new tracer call [ 11C ] NNC-112 . Healthy normal volunteer 18 70 year age may eligible study . Candidates screen physical examination blood urine test , include urine drug screen . Women age 55 also pregnancy test . Participants PET scan use [ 11C ] NNC-112 tracer . For procedure , catheter ( small plastic tube ) place vein subject 's arm injecting tracer . Then , subject lie scanner bed . After preliminary `` transmission scan , '' tracer inject , PET scan take head upper thigh period 2 hour show distribution radioactivity body . Blood pressure , breathe rate , heart rate check injection tracer , blood urine sample collect PET scan .</brief_summary>
	<brief_title>Positron Emission Tomography Imaging Dopamine Receptors Using Tracer 11CNNC-112</brief_title>
	<detailed_description>Abnormalities dopaminergic neurotransmission implicate several neurodegenerative psychiatric disorder , Parkinson 's disease , schizophrenia , attention-deficit-hyperactivity disorder drug dependence . Among Dopamine ( DA ) receptor , D1 receptor understand involved regulation motor cognitive activity modulate DAergic function . Neuroreceptor image Positron Emission Tomography ( PET ) Single Photon Emission Computerized Tomography ( SPECT ) allow vivo quantification density distribution D1 receptor human . Recently , new superior PET radioligand vivo quantification D1 receptor extrastriatal region develop . [ 11C ] NNC-112 D1 radiotracer high specific nonspecific binding , make suitable image low density D1 receptor extrastriatal region neocortex . Several study human confirm potential radiotracer , however , date , dosimetry study [ 11C ] NNC-112 human perform . The specific objective protocol estimate radiation-absorbed dos [ 11C ] NNC-112 human subject . For purpose , propose perform kinetic whole body image study [ 11C ] NNC-112 healthy human subject . We hypothesize level radiation-absorbed dos [ 11C ] NNC-112 human within limit , consequently , able move next stage image research , use radioligand measure density distribution D1 receptors Parkinson 's disease .</detailed_description>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<criteria>INCLUSION CRITERIA All subject must healthy age 1870 year . EXCLUSION CRITERIA Current psychiatric disease , substance abuse severe systemic disease base history physical exam Laboratory test clinically significant abnormality More moderate hypertension Any prior participation research protocol within past year involve radiation , exception plain radiography study ( i.e. , chest xrays ) . Pregnancy Breast Feeding Positive HIV test</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Biodistribution</keyword>
	<keyword>MIRD</keyword>
	<keyword>Radiation Absorbed Dose</keyword>
	<keyword>Healthy</keyword>
	<keyword>Prefrontal Cortex</keyword>
	<keyword>Radiation Exposure</keyword>
	<keyword>PET</keyword>
	<keyword>Dopamine D1 Receptor</keyword>
	<keyword>( 11C ) NNC-112</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>